Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

How our clients use DrugPatentWatch

Generated: April 24, 2017

DrugPatentWatch Database Preview

CLEOCIN Drug Profile

« Back to Dashboard

What is the patent landscape for Cleocin, and when can generics launch?

Cleocin is a drug marketed by Pharmacia And Upjohn and is included in fourteen NDAs. There is one patent protecting this drug.

This drug has twenty-one patent family members in twenty-two countries.

The generic ingredient in CLEOCIN is clindamycin phosphate. There are fifty-two drug master file entries for this compound. Thirty-two suppliers are listed for this compound. Additional details are available on the clindamycin phosphate profile page.

Summary for Tradename: CLEOCIN

Patents:1
Applicants:1
NDAs:14
Suppliers / Packagers: see list4
Bulk Api Vendors: see list102
Clinical Trials: see list4
Patent Applications: see list1,052
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:CLEOCIN at DailyMed

Pharmacology for Tradename: CLEOCIN

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Pharmacia And Upjohn
CLEOCIN
clindamycin hydrochloride
CAPSULE;ORAL061809-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
Pharmacia And Upjohn
CLEOCIN T
clindamycin phosphate
LOTION;TOPICAL050600-001May 31, 1989ABRXYesYes► Subscribe► Subscribe
Pharmacia And Upjohn
CLEOCIN
clindamycin phosphate
CREAM;VAGINAL050680-001Aug 11, 1992DISCNNoNo► Subscribe► Subscribe
Pharmacia And Upjohn
CLEOCIN
clindamycin phosphate
SWAB;TOPICAL050537-002Feb 22, 1994ATRXYesNo► Subscribe► Subscribe
Pharmacia And Upjohn
CLEOCIN PHOSPHATE
clindamycin phosphate
INJECTABLE;INJECTION062803-001Oct 16, 1987APRXNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Subscribe for Complete Access

  • Anticipate P&T budget requirements
  • Analyze global market entry opportunities
  • Set up watchlists for daily email updates

► Plans and Pricing

Expired Orange Book Patents

 Available with subscription

Paragraph IV Activity

 Available with subscription

Patent Maintenance

 Available with subscription

Non-Orange Book Patents

 Available with subscription

International Patents

 Available with subscription

Supplementary Protection Certificates

 Available with subscription

« Back to the Dashboard

For more information try a trial or see the database preview and plans and pricing

How our clients use DrugPatentWatch

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot